• LAST PRICE
    4.7800
  • TODAY'S CHANGE (%)
    Trending Up0.2700 (5.9867%)
  • Bid / Lots
    4.7700/ 12
  • Ask / Lots
    4.7800/ 2
  • Open / Previous Close
    4.6800 / 4.5100
  • Day Range
    Low 4.6299
    High 4.8250
  • 52 Week Range
    Low 1.1111
    High 6.7200
  • Volume
    464,219
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 4.51
TimeVolumeABSI
09:32 ET234804.7458
09:34 ET10984.73
09:36 ET9004.735
09:38 ET26984.7
09:39 ET54334.69
09:41 ET16004.69
09:43 ET27114.67
09:45 ET29774.69
09:48 ET13504.685
09:50 ET12344.67
09:52 ET2804.665
09:54 ET54654.635
09:56 ET40004.66
09:57 ET17334.66
09:59 ET3004.66
10:01 ET7004.65
10:03 ET16384.65
10:06 ET7004.63
10:08 ET228214.7
10:10 ET20004.67
10:14 ET19284.6619
10:15 ET47384.65
10:17 ET3724.66
10:19 ET5004.66
10:21 ET30514.67
10:24 ET65774.69
10:26 ET26674.69
10:28 ET25244.7
10:30 ET19694.705
10:32 ET103164.735
10:33 ET78654.78
10:35 ET53674.8
10:37 ET23954.79
10:39 ET13964.77
10:42 ET8004.74
10:46 ET16924.74
10:48 ET10174.72
10:50 ET24664.71
10:53 ET10854.74
10:55 ET49854.75
10:57 ET5004.75
11:00 ET10864.745
11:02 ET56164.75
11:04 ET2004.745
11:06 ET5004.745
11:08 ET4004.74
11:09 ET22254.73
11:11 ET22144.75
11:15 ET2004.74
11:18 ET74204.755
11:20 ET25484.775
11:22 ET15604.8
11:24 ET3004.805
11:26 ET16004.82
11:27 ET189574.82
11:29 ET42834.805
11:31 ET24224.79
11:33 ET86524.785
11:36 ET11674.77
11:40 ET18004.79
11:42 ET20004.7865
11:44 ET42684.78
11:45 ET17004.78
11:47 ET304374.75
11:49 ET10254.765
11:51 ET30704.745
11:54 ET39714.76
11:56 ET10004.7401
11:58 ET7004.75
12:00 ET22954.75
12:02 ET27454.72
12:03 ET53004.72
12:05 ET3004.715
12:07 ET30454.705
12:09 ET161584.73
12:12 ET19004.73
12:14 ET18564.73
12:16 ET27544.72
12:18 ET27114.715
12:20 ET18904.7399
12:21 ET57074.735
12:23 ET126334.735
12:27 ET1004.74
12:30 ET2994.73
12:32 ET10194.73
12:34 ET27264.735
12:36 ET7154.76
12:38 ET8524.76
12:39 ET12264.75
12:41 ET6004.75
12:43 ET2004.76
12:45 ET7124.7469
12:48 ET19694.745
12:50 ET5394.75
12:54 ET1004.741
12:56 ET2004.75
12:57 ET5004.7502
12:59 ET10264.755
01:01 ET6224.76
01:03 ET30004.755
01:06 ET7394.755
01:08 ET2004.755
01:10 ET38754.765
01:12 ET12454.7607
01:14 ET6004.7611
01:15 ET17864.755
01:17 ET27064.77
01:19 ET1504.7732
01:21 ET7004.77
01:24 ET14964.76
01:26 ET48574.76
01:28 ET7264.77
01:30 ET6254.765
01:32 ET12644.76
01:33 ET14004.73
01:35 ET3254.75
01:39 ET1004.745
01:42 ET5804.75
01:44 ET7444.745
01:46 ET7344.745
01:48 ET25024.755
01:50 ET7344.765
01:51 ET3004.765
01:53 ET3004.77
01:55 ET1264.765
01:57 ET15854.765
02:00 ET12564.765
02:02 ET98964.77
02:04 ET59724.78
02:06 ET38494.78
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesABSI
Absci Corp
511.1M
-4.1x
---
United StatesFULC
Fulcrum Therapeutics Inc
507.2M
-4.6x
---
United StatesALLO
Allogene Therapeutics Inc
508.5M
-1.5x
---
United StatesKALV
Kalvista Pharmaceuticals Inc
507.9M
-3.9x
---
United StatesATXS
Astria Therapeutics Inc
501.9M
-4.0x
---
United StatesCELC
Celcuity Inc
499.5M
-5.4x
---
As of 2024-06-12

Company Information

Absci Corporation is a generative artificial intelligence (AI) drug creation company. The Company combines AI with scalable wet lab technologies to create biologics for patients. It has built an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. The Company uses its platform to predict, identify, design, construct, screen, select and scale production of biologic drug candidates for its partners, and learn from the data it generates. Its SoluPro technology is a multiplex synthetic biology approach that overcomes the limitations of highest-throughput automation labs. The Company supports its generative AI designs with its wet lab's high-throughput functional validation capabilities. It reconstructs prevalent immune-response molecules, such as antibodies from disease tissue and identify their corresponding antigens, offering new therapeutic targets.

Contact Information

Headquarters
18105 Se Mill Plain BlvdVANCOUVER, WA, United States 98683
Phone
360-949-1041
Fax
302-655-5049

Executives

Chief Executive Officer, Founder, Director
Sean Mcclain
Chief Financial Officer, Chief Business Officer, Treasurer
Zachariah Jonasson
Chief Innovation Officer
Andreas Busch
Lead Independent Director
Karen Mcginnis
Independent Director
Amrit Nagpal

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$511.1M
Revenue (TTM)
$5.3M
Shares Outstanding
113.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.17
Book Value
$1.89
P/E Ratio
-4.1x
Price/Sales (TTM)
95.6
Price/Cash Flow (TTM)
---
Operating Margin
-2,141.91%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.